Adial Pharmaceuticals, Inc. Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Equity Interests
Adial Pharmaceuticals, Inc. (ADIL) reported Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Equity Interests of $1.73 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentEquityInterests · last filed 2024-08-13
- Adial Pharmaceuticals, Inc. business combination, provisional information, initial accounting incomplete, adjustment, equity interests for the quarter ending 2023-12-31 was $0.00.
- Adial Pharmaceuticals, Inc. business combination, provisional information, initial accounting incomplete, adjustment, equity interests for the quarter ending 2023-09-30 was $0.00.
- Adial Pharmaceuticals, Inc. business combination, provisional information, initial accounting incomplete, adjustment, equity interests for fiscal 2023 was $1.73M.
| Period end | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Equity Interests 3 month | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Equity Interests 6 month | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Equity Interests 9 month | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Equity Interests 12 month |
|---|---|---|---|---|
| 2024-06-30 | $1.73M 10-Q · filed 2024-08-13 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $1.73M 10-K · filed 2024-04-01 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-11-14 | $1.73M 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $1.73M 10-Q/A · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |